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SINCE it was first reported that unusual free floating cells had been established
in continuous culture from a Ugandan (Epstein and Barr, 1964) and a Nigerian
(Pulvertaft, 1964) case of Burkitt's tumour (Burkitt, 1958), numerous other
in vitro strains ofsuch cells have been grown from this singular human malignancy
(Epstein, Barr and Achong, 1964; Stewart, Lovelace, Whang and Ngu, 1965;
Epstein, Barr and Achong, 1965a; O'Conor and Rabson, 1965; Rabson.
O'Conor, Baron, Whang and Legallais, 1966; Osunkoya, 1966). The lympho-
blastic nature of the cells has been demonstrated by tissue culture, light micro-
scope, and fine structural studies (Epstein and Barr, 1965; Epstein and Achong,
1965; Epstein, Barr and Achong, 1965a and b; Stewart, Lovelace, Whang and
Ngu, 1965; Rabson, O'Conor, Baron, Whang and Legallais, 1]966; Epstein,
Achong, Barr, Zajac, Henle and Henle, 1966) and their relationship shown to the
malignant element ofthe Burkitt lymphoma (Achong and Epstein, 1966; Epstein,
1966).
The fact that malignant lymphoblasts from Burkitt tumours can be cultured
relatively easily in vitro forms a marked contrast to the rarity with which this has
been achieved with pure cultures of human leukaemic cells of this type (Foley,
Lazarus, Farber, Uzman, Boone and McCarthy, 1965) and provides a further
reason for considering that the Burkitt tumour and its malignant cell constitute
a highly unusual special entity.
New strains oflymphoblasts (EB4 and EB5) have now been isolated in culture
from abdominal Burkitt lymphomas in a British and a Ugandan patient and the
present communication gives a brief preliminary report concerning their nature.
MATERIALS AND METHODS
Patients. - (i) The British patient was a 15 year old English girl admitted,
with abdominal enlargement, to Stepping Hill Hospital, Cheshire, and found to
have massive tumours of the right ovary and caecum. The clinical similarity
to Burkitt's lymphoma was close and this diagnosis was confirmed on histological
and cytological grounds by Dr. 0. G. Dodge and Dr. D. H. Wright. A full
account of this case is given elsewhere (Seed, 1966).
(ii) The Ugandan case involved a 20 year old male admitted to Mulago Hospital,
Kampala, with a four weeks' history of abdominal swelling, and found to have a
massive mesenteric lymphoma (Burkitt's case No. K 260). The diagnosis of
Burkitt's tumour was confirmed histologically (Fig. 1).M. A. EPSTEIN, Y. M. BARR AND B. G. ACHONG
Tumour material.-Biopsy samples were taken during laparotomy under
general anaesthesia; material was removed from the caecal tumour in the British
patient and from the mesenteric mass in the TUgandan patient.
Preparation and maintenance of cultures.-Tumour cells were teased free from
the biopsy samples and were set up in culture in insulin bottles by the definitive
method already described (Epstein and Barr, 1965). For the material from the
British case Eagles basal medium (EBM) was used for 6 cultures and Eagles
minimal essential medium (MEM) for another 6; the latter medium was used to
initiate growth with 7 cultures of the Ugandan tumour. All the cultures were
kept stationary and were divided every three or four days when growth was
observed.
Cell counts.-The cells were counted by the methods used in earlier work
(Epstein and Barr, 1965) whenever the cultures were fed and divided.
Where the rate of cell growth was to be determined, four 25 ml. conical flasks
were set up with portions of a given cell population together with an equal volume
of fresh medium to give the same number of cells in the region of 500,000 per ml.,
in each flask; the flasks were incubated and duplicate daily cell counts were
made.
Preparation of cellsfor light and electron microscopy.-The techniques for these
procedures have been described in detail elsewhere (Epstein and Achong, 1965;
Achong and Epstein, 1965).
OBSERVATIONS
Early proliferation.-After 18 days' incubation a fall in pH occurred in 1 ofthe
12 insulin bottles containing cells from the British patient, and after 15 days in
3 of the 7 bottles with cells from the UJgandan case. On examination in wet film
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FIG. 1. Photomicrograph of the biopsy specimen removed from the mesenteric mass in a
20 year old Ugandan man, from which EB5 cells were cultured. Sheets of lymphoid cells
lie between strands of fibrous tissue; some scattered large clear histiocytes can be seen.
The diagnosis of Burkitt's lymphoma was made by Dr. D. H. Wright. Haemotoxylin
and eosin. x 250.
FIG. 2. Phase constrast photomicrograph of living EB4 lymphoblasts. The cells are regular,
about 7 ,u in diameter, mostly rounded and have not attached to the glass of the container
or formed clumps. x 290.
FIG. 3.-Phase contrast photomicrograph of living EB5 lymphoblasts, presenting the same
features as the EB4 strain shown in Fig. 2, except for a slight tendency for groups of 3 or 4
cells to adhere. Transient small clumps have sometimes been observed in cultures of this
strain. x 290.
FIG. 6.-Leishman stained air dried film of cultured EB4 lymphoblasts showing the rounded
or oval nuclei and narrow basophilic cytoplasm with numerous clear vacuoles. x 535.
FIG. 7. Leishman stained film of cultured EB5 lymphoblasts showing the same features as
are illustrated in the EB4 cells of Fig. 6. x 535.
FIG. 8. Survey electronmicrograph of a thin section through a group of EB4 lymphoblasts
showing the characteristic features of the cells. The large nuclei are rounded and mainly
smooth, contain prominent nucleoli and a thin rim of marginated chromatin. The rela-
tively narrow cytoplasm is packed with uniformly dispersed free ribosomes and contains
mitochondria (m) in groups, and some lipid bodies (ii). Elements of the rough endoplasmic
reticulum (arrow8) and Golgi components (g) are very scanty. Glutaraldehyde and osmium
fixation with epoxy resin embedding; section contrast-stained with uranyl acetate.
x 8,400.
FIG. 9.-Survey electronmicrograph of EB5 lymphoblasts prepared in the same way as the
cells of Fig. 8 and showing the same features. Grouped mitochondria are marked at m, a
lipid body at 1i and scanty endoplasmic reticulum by an arrow. The cell in the upper right
corner of the field is in mitosis. x 8,400.
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preparations clear round viable cells were observed; those from the British case
were designated EB4 and those from the 'Igandan case EB5. The cultures
showing proliferation had all been fed with MEM.
Mode ofcell growth.-Both cell strains have grown in suspension as free floating
individuals without attachment to glass (Fig. 2 and 3); occasional transient
clumps have been observed in the EB5 cultures. The EB4 strain has been
maintained in vitro so far for 271 days, and the EB5 strain for 240 days.
During periods of active growth the doubling time of each cell strain has been
between 24 and 36 hours (Fig. 4 and 5). The average maximum cell count in
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FIG. 4.-Growth rate of EB4 lymphoblasts during the 19th week of culture showing the mean
of duplicate counts on each of 4 cultures (paired symbols except where superimposed).
After a slight initial drop in cell numbers the doubling time during the period of active
growth in the second and third days was 24 hours.
FIG. 5.-Growth rate of EB5 lymphoblasts during the 17th week of culture showing the
mean ofduplicate counts on each of 4 cultures (paired symbols except where superimposed).
After a slight initial drop in cell numbers the doubling time during the period of active
growth in the second and third days was 36 hours.
EB4 cultures has been in the region of 1.5 million per ml., whilst that in the EB5
cultures was slightly less at about 1 million per ml.
Cell morphology.-The cells of each strain are about 7 ,u in diameter when
measured in the living state by phase-contrast microscopy, and after Leishmann
staining closely resemble those reported earlier (Epstein and Barr, 1965; Epstein,
Barr and Achong, 1965a and b) with basophilic cytoplasm containing clear
vacoules, and large rounded or oval nuclei with several nucleoli (Fig. 6 and 7).
Electron microscopy has confirmed the cell size and that each strain consists
of a single cell type whose fine structural organisation is that of a differentiated
lymphoblast (Fig. 8 and 9) (Bernhard and Leplus, 1964). Annulate lamellae
have been found readily in EB4 cells and rarely in EB5 cells; loop-shaped pro-
jections of the nuclear envelope into the cytoplasm (Epstein and Achong, 1965;
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Epstein, Barr and Achong, 1965b; Achong and Epstein, 1966) were equally
common in both strains.
DISCUSSION
On the basis oftheir behaviour and growth in vitro, their appearance in stained
films and their fine structural organisation, the cells of the EB4 and EB5 strains
are clearly ofthe same general lymphoblastic type as all the other cells established
previously in culture from Burkitt tumours (Epstein and Barr, 1964; Pulvertaft,
1964; Epstein, Barr and Achong, 1964; Stewart, Lovelace, Whang and Ngu,
1965; Epstein, Barr and Achong, 1965a; O'Conor and Rabson, 1965; Rabson,
O'Conor, Baron, Whang, and Legallais, 1966; Osunkoya, 1966). In terms of
detail, both the EB4 and EB5 cells are differentiated rather than undifferentiated
lymphoblasts and therefore closer to EBI (Epstein and Barr, 1965) and EB3 cells
(Epstein, Barr and Achong, 1965a) than to the undifferentiated EB2 (Epstein,
Barr and Achong, 1965b), SL1 (Stewart, Lovelace, Whang and Ngu, 1965) or
Raji cells (Pulvertaft, 1964; Epstein, Achong, Barr, Zajac, Henle and Henle,
1966); this is shown by their small size, regular rounded nuclei, relatively re-
stricted cytoplasm and proliferation as single cells without forming regular
clumps (Fig. 2, 3, 6 to 9).
The fact that two new strains of Burkitt tumour lymphoblasts have been
established in vitro is of interest since this provides further examples of the
relative ease with which such lymphoblasts can be cultured and therefore evi-
dence of the special nature of this tumour cell. In this connection the origin of
the EB4 strain from a British patient supports the view that the rare cases in
Western countries which resemble the Burkitt tumour clinically (Dorfman,
1965; O'Conor, Rappaport and Smith, 1965; Wright, 1965) arise from the
same, unusual, propagable, malignant cell as the Burkitt tumour in Africa.
The successful culture of tumour cells from an ovarian Burkitt lymphoma in a
white American patient (O'Conor and Rabson, 1965) is an exactly parallel
example.
It has been known for some time that cultured lymphoblasts from African
Burkitt lymphomas, as well as from the American case, carry an unidentifiable,
new, herpes-like virus (Epstein, Achong and Barr, 1964; Epstein, Barr and
Achong, 1964; Stewart, Lovelace, Whang and Ngu, 1965; Epstein, Barr and
Achong, 1965a; O'Conor and Rabson, 1965; Rabson, O'Conor, Baron, Wang,
and Legallais, 1966) which might, perhaps, play some role in the aetiology
of the Burkitt lymphoma (Epstein, Henle, Achong and Barr, 1965; Epstein,
Achong and Barr, 1966). The EB4 and EB5 strains of Burkitt tumour cells
described in the present paper provide new material for virological study in order
further to investigate this possibility.
SUMMARY
Two new strains of cells (EB4, EB5) have been established in culture from
caecal and mesenteric Burkitt tumours in a 15 year old English girl and a 20
year old Ugandan man respectively. The cells of each strain have grown in
suspension as single individuals with only rare transient clumps and are continuing
to proliferate after more than 8 months. The doubling time of the cells during
periods of active growth has varied between 24 and 36 hours. The cells of each
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strain measure about 7 ,u in diameter, are rounded and regular, and at the fine
structural level show the features of differentiated lymphoblasts; they also
contain annulate lamellae and loop-shaped projections of the nuclear envelope.
Both the EB4 and EB5 cells are currently being investigated for the presence
of virus.
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